Live Breaking News & Updates on Michael fitzhugh

Stay informed with the latest breaking news from Michael fitzhugh on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Michael fitzhugh and stay connected to the pulse of your community

Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD

SOUTH SAN FRANCISCO, Calif., April 25, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical

Jordyn-tarazi , Lawrence-blatt , Michael-fitzhugh , Stephena-harrison , Lifesci-communications , Exchange-commission-on , Nasdaq , Principal-investigator-for-the-company , Aligos-therapeutics-inc , Exchange-commission , Investor-relations-corporate-communications , Principal-investigator

Cidara Therapeutics Announces Presentations Highlighting Phase 1 and Phase 2a Clinical Data on CD388 at ESCMID 2024 - Cidara Therapeutics (NASDAQ:CDTX)

SAN DIEGO, April 26, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (NASDAQ:CDTX), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed

Barcelona , Comunidad-autonoma-de-cataluna , Spain , San-diego , California , United-states , Michael-fitzhugh , Roxanae-rojas , Ruben-faelens , Jeffrey-stein , Brian-ritchie , Lifesci-communications

Aligos Therapeutics Mourns the Passing of MASH Industry Leader Stephen A. Harrison, MD

SOUTH SAN FRANCISCO, Calif., April 25, 2024 -- Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in...

Lawrence-blatt , Jordyn-tarazi , Stephena-harrison , Michael-fitzhugh , Exchange-commission , Aligos-therapeutics-inc , Lifesci-communications , Principal-investigator-for-the-company , Investor-relations-corporate-communications , Exchange-commission-on , Nasdaq , Principal-investigator

Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million

Cidara Therapeutics Reacquires Global Development and Commercial Rights to CD388 and Announces Private Placement Financing of $240 Million
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San-diego , California , United-states , James-merson , Michael-fitzhugh , David-gollaher , Timothy-franson , Laura-tadvalkar , Ryan-spencer , Jessica-sagers , Brian-ritchie , Jeffrey-stein

Skye Bioscience to Present at Upcoming Investment Conferences

Skye Bioscience to Present at Upcoming Investment Conferences
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

New-york , United-states , Mike-moyer , Punit-dhillon , Michael-fitzhugh , Skye-bioscience , Lifesci-communications , Exchange-commission , Life-sciences-conference , Skye-bioscience-inc , Nasdaq , Upcoming-investment

Recce Pharmaceuticals Provides Business Update

Promising Minimum Inhibitory Concentration (MIC) activity in Phase I/II trial for urinary tract infections (UTI) and urosepsis with an increase in dosage expected to begin in the next several weeksExpansion of Phase I/II trial for diabetic foot infections (DFI) with efficacy achieved and now moving towards the initiation of a Phase III registrational trial in Indonesia scheduled to commence in Q3 2024RECCE® 327 (R327) shown to be effective against more than 300 strains of bacterial pathogens dur

Indonesia , United-states , Australia , Sydney , New-south-wales , Australian , American , James-graham , Andrew-geddes , John-prendergast , Alanw-dunton , Michael-fitzhugh

Aligos Therapeutics to Participate in the Piper Sandler Spring Biopharma Symposium 2024

SOUTH SAN FRANCISCO, Calif., April 09, 2024 -- Aligos Therapeutics, Inc. , a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in...

Boston , Massachusetts , United-states , Michael-fitzhugh , Piper-sandler , Jordyn-tarazi , Investor-relations-corporate-communications , Lifesci-communications , Aligos-therapeutics-inc , Nasdaq , Piper-sandler-spring-biopharma-symposium , Investor-relations

Recce Pharmaceuticals Granted New Patent in Israel for RECCE® Anti-Infectives

SYDNEY, Australia, April 04, 2024 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q), the Company developing a new class of synt...

Australia , United-states , Sydney , New-south-wales , London , City-of , United-kingdom , Israel , Ross-river , Queensland , State-of-israel , Israeli

Recce Pharmaceuticals to Present at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) 2024 Annual Meeting

Recce Pharmaceuticals to Present at the American Society for Clinical Pharmacology & Therapeutics (ASCPT) 2024 Annual Meeting
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Colorado , United-states , Colorado-springs , Sydney , New-south-wales , Australia , Guillame-van-renterghem , James-graham , Michael-fitzhugh , Michele-diliza , Andrew-geddes , Recce-pharmaceuticals-ltd